nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—Progressive multifocal leukoencephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0643	0.0643	CcSEcCtD
Darunavir—Acute respiratory distress syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0333	0.0333	CcSEcCtD
Darunavir—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.0267	0.0267	CcSEcCtD
Darunavir—Non-Hodgkin's lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0249	0.0249	CcSEcCtD
Darunavir—Lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.0249	0.0249	CcSEcCtD
Darunavir—Renal tubular necrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0244	0.0244	CcSEcCtD
Darunavir—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0198	0.0198	CcSEcCtD
Darunavir—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.0188	0.0188	CcSEcCtD
Darunavir—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.0188	0.0188	CcSEcCtD
Darunavir—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.0183	0.0183	CcSEcCtD
Darunavir—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.0177	0.0177	CcSEcCtD
Darunavir—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0161	CcSEcCtD
Darunavir—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0151	CcSEcCtD
Darunavir—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0138	CcSEcCtD
Darunavir—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.0133	0.0133	CcSEcCtD
Darunavir—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0121	CcSEcCtD
Darunavir—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0115	CcSEcCtD
Darunavir—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Darunavir—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0111	CcSEcCtD
Darunavir—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0107	CcSEcCtD
Darunavir—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Darunavir—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00983	0.00983	CcSEcCtD
Darunavir—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0097	0.0097	CcSEcCtD
Darunavir—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00963	0.00963	CcSEcCtD
Darunavir—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00957	0.00957	CcSEcCtD
Darunavir—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00944	0.00944	CcSEcCtD
Darunavir—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00938	0.00938	CcSEcCtD
Darunavir—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00938	0.00938	CcSEcCtD
Darunavir—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00932	0.00932	CcSEcCtD
Darunavir—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00886	0.00886	CcSEcCtD
Darunavir—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.0087	0.0087	CcSEcCtD
Darunavir—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00855	0.00855	CcSEcCtD
Darunavir—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00855	0.00855	CcSEcCtD
Darunavir—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0084	0.0084	CcSEcCtD
Darunavir—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00786	0.00786	CcSEcCtD
Darunavir—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00786	0.00786	CcSEcCtD
Darunavir—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00778	0.00778	CcSEcCtD
Darunavir—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00755	0.00755	CcSEcCtD
Darunavir—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00726	0.00726	CcSEcCtD
Darunavir—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00719	0.00719	CcSEcCtD
Darunavir—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00706	0.00706	CcSEcCtD
Darunavir—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00703	0.00703	CcSEcCtD
Darunavir—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00703	0.00703	CcSEcCtD
Darunavir—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00681	0.00681	CcSEcCtD
Darunavir—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00672	0.00672	CcSEcCtD
Darunavir—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00666	0.00666	CcSEcCtD
Darunavir—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00663	0.00663	CcSEcCtD
Darunavir—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0065	0.0065	CcSEcCtD
Darunavir—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.00647	CcSEcCtD
Darunavir—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00644	0.00644	CcSEcCtD
Darunavir—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.00626	CcSEcCtD
Darunavir—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00622	0.00622	CcSEcCtD
Darunavir—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00598	0.00598	CcSEcCtD
Darunavir—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.00592	CcSEcCtD
Darunavir—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.00579	CcSEcCtD
Darunavir—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00571	0.00571	CcSEcCtD
Darunavir—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00559	0.00559	CcSEcCtD
Darunavir—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00557	0.00557	CcSEcCtD
Darunavir—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.00549	CcSEcCtD
Darunavir—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00535	0.00535	CcSEcCtD
Darunavir—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00523	CcSEcCtD
Darunavir—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0051	0.0051	CcSEcCtD
Darunavir—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.00504	CcSEcCtD
Darunavir—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00497	0.00497	CcSEcCtD
Darunavir—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.00494	CcSEcCtD
Darunavir—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00492	CcSEcCtD
Darunavir—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.00487	CcSEcCtD
Darunavir—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.00487	CcSEcCtD
Darunavir—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.0048	CcSEcCtD
Darunavir—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.00478	CcSEcCtD
Darunavir—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.00477	CcSEcCtD
Darunavir—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00477	0.00477	CcSEcCtD
Darunavir—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.00474	CcSEcCtD
Darunavir—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.00474	CcSEcCtD
Darunavir—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00464	0.00464	CcSEcCtD
Darunavir—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.0046	CcSEcCtD
Darunavir—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00459	0.00459	CcSEcCtD
Darunavir—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00439	CcSEcCtD
Darunavir—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00437	CcSEcCtD
Darunavir—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00437	CcSEcCtD
Darunavir—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00435	0.00435	CcSEcCtD
Darunavir—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.00431	CcSEcCtD
Darunavir—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00429	CcSEcCtD
Darunavir—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00428	0.00428	CcSEcCtD
Darunavir—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.00421	CcSEcCtD
Darunavir—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00405	0.00405	CcSEcCtD
Darunavir—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00396	CcSEcCtD
Darunavir—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.00394	CcSEcCtD
Darunavir—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.00392	CcSEcCtD
Darunavir—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00386	CcSEcCtD
Darunavir—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.00383	CcSEcCtD
Darunavir—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.0038	CcSEcCtD
Darunavir—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.00375	CcSEcCtD
Darunavir—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00372	0.00372	CcSEcCtD
Darunavir—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00366	CcSEcCtD
Darunavir—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00353	CcSEcCtD
Darunavir—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.00351	CcSEcCtD
Darunavir—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00349	CcSEcCtD
Darunavir—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00347	CcSEcCtD
Darunavir—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.00343	CcSEcCtD
Darunavir—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.00342	CcSEcCtD
Darunavir—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.0034	CcSEcCtD
Darunavir—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00332	0.00332	CcSEcCtD
Darunavir—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.00329	CcSEcCtD
Darunavir—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00328	0.00328	CcSEcCtD
Darunavir—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00324	CcSEcCtD
Darunavir—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00324	CcSEcCtD
Darunavir—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00324	CcSEcCtD
Darunavir—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00323	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00322	CcSEcCtD
Darunavir—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.0032	CcSEcCtD
Darunavir—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.00317	CcSEcCtD
Darunavir—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.00313	CcSEcCtD
Darunavir—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00304	CcSEcCtD
Darunavir—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00304	CcSEcCtD
Darunavir—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00301	CcSEcCtD
Darunavir—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.003	CcSEcCtD
Darunavir—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00296	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00283	CcSEcCtD
Darunavir—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00281	CcSEcCtD
Darunavir—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00279	CcSEcCtD
Darunavir—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00277	CcSEcCtD
Darunavir—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00276	CcSEcCtD
Darunavir—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00273	CcSEcCtD
Darunavir—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.0027	CcSEcCtD
Darunavir—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00268	CcSEcCtD
Darunavir—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00268	CcSEcCtD
Darunavir—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00265	CcSEcCtD
Darunavir—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00265	CcSEcCtD
Darunavir—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00256	CcSEcCtD
Darunavir—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00254	CcSEcCtD
Darunavir—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00247	CcSEcCtD
Darunavir—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00245	CcSEcCtD
Darunavir—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00245	CcSEcCtD
Darunavir—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00229	CcSEcCtD
Darunavir—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00223	CcSEcCtD
Darunavir—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.0022	CcSEcCtD
Darunavir—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00212	CcSEcCtD
Darunavir—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00205	CcSEcCtD
Darunavir—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00197	CcSEcCtD
Darunavir—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00196	CcSEcCtD
Darunavir—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00195	CcSEcCtD
Darunavir—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00194	CcSEcCtD
Darunavir—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00184	CcSEcCtD
